In other malignancies, such as colorectal cancer (CRC) and small cell lung cancer (SCLC), SOX2 often correlates with worse survival, chiefly through its roles in promoting stemness, chemoresistance, and EMT [44,45]. Here, SOX2 is linked to small cell lung carcinoma.